Clinical Trials Browser

Has results × Prostatic Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00272038 2018-06-27

Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer

Phase 2 Completed

29 enrolled 8 charts

Prostatic Neoplasms